Evidence map›Paper›PMID 29187586›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Live Attenuated

Antara Banerjee, Parna Bhattacharya, Pradeep K Dagur, Subir Karmakar, Nevien Ismail, Amritanshu B Joshi, Adovi D Akue, Mark KuKuruga, John Philip McCoy, Ranadhir Dey and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. LmCenNPJ vaccines · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  11. The History of Live AttenuatedPathogens (Basel, Switzerland) · 2022
    Review
  12. Revisiting the Principles of Designing a Vaccine.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  13. Article
  14. Expression Profile of Genes Related to the Th17 Pathway in Macrophages Infected byFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Revival of Leishmanization and Leishmanin.Frontiers in cellular and infection microbiology · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Antara BanerjeeDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.
Parna BhattacharyaDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.
Pradeep K DagurFlow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; and.
Subir KarmakarDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.
Nevien IsmailDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.ORCID 0000-0003-0294-8834
Amritanshu B JoshiDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.ORCID 0000-0003-2826-3817
Adovi D AkueOffice of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.
Mark KuKurugaOffice of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.ORCID 0000-0002-9500-7576
John Philip McCoyFlow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; and.
Ranadhir DeyDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993; Hira.Nakhasi@fda.hhs.gov Ranadhir.Dey@fda.hhs.gov.
Hira L NakhasiDivision of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993; Hira.Nakhasi@fda.hhs.gov Ranadhir.Dey@fda.hhs.gov.
Center for Biologics Evaluation and Research · USNational Institutes of Health · US

Funding

Flow Cytometry Core FacilityZICHL005905 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DAGUR, PRADEEP · 2009 to 2025
$32.3M
Intramural NIH HHS ZIC HL005905
6 · The paper itself

Abstract

No vaccine exists against visceral leishmaniasis. To develop effective vaccines, we have previously reported protective role of live attenuated centrin gene-deleted

Indexed as

AnimalsAnimals, Genetically ModifiedFemaleHumansInterleukin-17Interleukin-23Leishmania donovaniLeishmaniasis VaccinesLeishmaniasis, VisceralMiceMice, Inbred C57BLMice, KnockoutProtozoan ProteinsReceptors, InterleukinTh17 CellsTh1 CellsInterleukin-17Interleukin-23interleukin-23 receptor, mouseLeishmaniasis VaccinesProtozoan ProteinsReceptors, InterleukinVaccines, Attenuated

Identifiers

PMID29187586
PMCPMC6532400
OpenAlexW2774127248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.